Biopharmaceutical firm Hutchmed China Ltd., backed by billionaire Li Ka-shing, has agreed to sell stakes in a health unit for about $608 million as the group seeks to generate capital and focus on its core businesses.
Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million
You May Also Like
Where the next financial crisis could emerge
January 4, 2025
Big Tech's H-1B Visa Future
January 4, 2025
USW’s McCall Says US Steel Viable, Backs Biden Decision
January 4, 2025
+ There are no comments
Add yours